AR049425A1 - N- SULFAMOIL -N'- ARILPIPERAZINAS, PROCEDURE FOR THE PREPARATION, PHARMACEUTICAL COMPOSITION AND ITS USE FOR THE PREPARATION OF SUCH PHARMACEUTICAL COMPOSITIONS - Google Patents
N- SULFAMOIL -N'- ARILPIPERAZINAS, PROCEDURE FOR THE PREPARATION, PHARMACEUTICAL COMPOSITION AND ITS USE FOR THE PREPARATION OF SUCH PHARMACEUTICAL COMPOSITIONSInfo
- Publication number
- AR049425A1 AR049425A1 ARP050101995A AR049425A1 AR 049425 A1 AR049425 A1 AR 049425A1 AR P050101995 A ARP050101995 A AR P050101995A AR 049425 A1 AR049425 A1 AR 049425A1
- Authority
- AR
- Argentina
- Prior art keywords
- whose
- aryl
- preparation
- cyclic system
- substituents
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente trata de N-sulfamoil-N'-arilpiperazinas, procedimientos para su preparacion, composicion farmacéutica, y su uso para la preparacion de dichas composiciones farmacéuticas, composicion farmacéutica que los comprende. Reivindicacion 1: Uso de un compuesto de la formula (1) en la cual Ar representa un radical C6-10-arilo, monocíclico o bicíclico, cuyos átomos de carbono cíclicos están opcionalmente reemplazados una a tres veces por nitrogeno, oxígeno y/o azufre, y/o cuyo sistema cíclico C6-10-arilo contiene opcionalmente tres a cinco dobles ligaduras y/o cuyo sistema cíclico C6-10-arilo está opcionalmente sustituido con uno, dos o tres sustituyentes que pueden ser iguales o distintos entre sí y que están elegidos del grupo que comprende halogeno, carboxilo, hidroxilo, hidroxicarbamoilo, trifluorometil, ciano, nitro, pirrolidinilo, C1-4-alquilo, C1-4-alcoxi, C0-4-alcoxifenilo, C1-4-alquiltio, C2-4-alcanoilo, C1-4-alquiloxicarbonilo, C1-4-alquilsulfonilo, y dos átomos de oxígeno ligados a dos átomos de carbono adyacentes del sistema cíclico C6-10-arilo y que están puenteados por C1-2-alquileno; o cuyo sistema cíclico C6-10- arilo está sustituido con uno o dos sustituyentes que pueden ser iguales o distintos entre sí y elegidos del grupo que comprende halogeno, carboxilo, hidroxilo, hidroxicarbamoilo, trifluorometilo, ciano, nitro, C1-4-alquilo, C1-4-alcoxi, C1-4-alquiltio, C2-4-alcanoilo, C1-4-alquiloxicarbonilo, C1-4-alquil-sulfonilo, dos átomos de oxígeno ligados a dos átomos de carbono adyacentes del sistema cíclico C6-10-arilo y puenteados por C1-2-alquileno; o cuyo sistema cíclico C6-10-arilo está sustituido con tienilo, naftilo, piridilo, fenilo o bencilo, cada uno de cuyos sustituyentes fenilo o bencilo están opcionalmente sustituido en el ciclo fenilo con uno, dos o tres sustituyentes pueden ser iguales o distintos entre sí y elegidos del grupo que comprende halogeno, trifluorometilo, ciano, C1-6-alquilo, C1-4-alcoxi o C1-4- alquilsulfonilo, o sus sales de adicion de ácido fisiologicamente compatibles, para la preparacion de un medicamento para el tratamiento y/o profilaxis de obesidad y sus condiciones o enfermedades secundarias y/o concomitantes.This is about N-sulfamoyl-N'-arylpiperazines, processes for their preparation, pharmaceutical composition, and their use for the preparation of said pharmaceutical compositions, pharmaceutical composition comprising them. Claim 1: Use of a compound of the formula (1) in which Ar represents a C6-10-aryl, monocyclic or bicyclic radical, whose cyclic carbon atoms are optionally replaced one to three times by nitrogen, oxygen and / or sulfur , and / or whose C6-10-aryl cyclic system optionally contains three to five double ligatures and / or whose C6-10-aryl cyclic system is optionally substituted with one, two or three substituents that may be the same or different from each other and that are chosen from the group comprising halogen, carboxyl, hydroxyl, hydroxycarbamoyl, trifluoromethyl, cyano, nitro, pyrrolidinyl, C1-4-alkyl, C1-4-alkoxy, C0-4-alkoxyphenyl, C1-4-alkylthio, C2-4- alkanoyl, C1-4-alkyloxycarbonyl, C1-4-alkylsulfonyl, and two oxygen atoms linked to two adjacent carbon atoms of the C6-10-aryl cyclic system and which are bridged by C1-2-alkylene; or whose C6-10-aryl cyclic system is substituted with one or two substituents that may be the same or different from each other and chosen from the group comprising halogen, carboxyl, hydroxyl, hydroxycarbamoyl, trifluoromethyl, cyano, nitro, C1-4-alkyl, C1-4-alkoxy, C1-4-alkylthio, C2-4-alkanoyl, C1-4-alkyloxycarbonyl, C1-4-alkyl sulfonyl, two oxygen atoms linked to two adjacent carbon atoms of the C6-10- cyclic system aryl and bridged by C1-2-alkylene; or whose C6-10-aryl cyclic system is substituted with thienyl, naphthyl, pyridyl, phenyl or benzyl, each of whose phenyl or benzyl substituents are optionally substituted in the phenyl cycle with one, two or three substituents may be the same or different from yes and chosen from the group comprising halogen, trifluoromethyl, cyano, C1-6-alkyl, C1-4-alkoxy or C1-4-alkylsulfonyl, or their physiologically compatible acid addition salts, for the preparation of a medicament for the treatment and / or obesity prophylaxis and its secondary and / or concomitant conditions or diseases.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04102210 | 2004-05-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR049425A1 true AR049425A1 (en) | 2006-08-02 |
Family
ID=34929117
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP050101995 AR049425A1 (en) | 2004-05-19 | 2005-05-16 | N- SULFAMOIL -N'- ARILPIPERAZINAS, PROCEDURE FOR THE PREPARATION, PHARMACEUTICAL COMPOSITION AND ITS USE FOR THE PREPARATION OF SUCH PHARMACEUTICAL COMPOSITIONS |
Country Status (3)
Country | Link |
---|---|
AR (1) | AR049425A1 (en) |
TW (1) | TW200602057A (en) |
UA (1) | UA86416C2 (en) |
-
2005
- 2005-05-13 TW TW094115582A patent/TW200602057A/en unknown
- 2005-05-16 AR ARP050101995 patent/AR049425A1/en not_active Application Discontinuation
- 2005-05-18 UA UAA200613288A patent/UA86416C2/en unknown
Also Published As
Publication number | Publication date |
---|---|
TW200602057A (en) | 2006-01-16 |
UA86416C2 (en) | 2009-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1125292T1 (en) | 6,7,8,9-TETPAYDP-3H-PYPAZOLO[4,3-F ISOQUINOLINE DERIVATIVES USEFUL IN THE THERAPEUTIC TREATMENT OF CANCER | |
AR072791A1 (en) | DERIVATIVES OF TIAZOLIDIN-2, 4-DIONA, METHODS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM AND THEIR USE IN THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF CANCER. | |
ATE517882T1 (en) | QUINOLINE DERIVATIVES | |
EA202092490A1 (en) | METHYL-MODIFYING ENZYMES MODULATORS, COMPOSITIONS AND THEIR APPLICATION | |
ECSP088747A (en) | PIRAZOLES AS INHIBITORS OF THE 11-BETA-HSD1 | |
EA200601802A1 (en) | DERIVATIVES OF MORPHOLINE | |
NO20064347L (en) | Substituted 1,2,3,4-tetrahydroisoquinoline derivatives | |
UY30183A1 (en) | QUINOLINE DERIVATIVES | |
BRPI0507198A (en) | bisarylurea derivatives | |
EA200971115A1 (en) | NEW HIV REVERSE TRANSCRIPTASE INHIBITORS | |
CL2011000306A1 (en) | Compounds derived from di-alkylamide of 7-cyclopentyl-2- [5- (piperidin or substituted piperazin) -pyridin-2-yl amino] -7h-pyrrolo- [2,3-d] -pyrimidin-6-carboxylic acid, cdk4 inhibitors; pharmaceutical composition; and its use for the treatment of cancer or inflammation. | |
CL2022001743A1 (en) | Gamma-Hydroxybutyrate (GHB) Dosage | |
DK1519724T3 (en) | Fredericamycin derivatives as drugs for the treatment of tumors | |
AR075587A1 (en) | BIFENYLATE DERIVATIVES FOR THE TREATMENT OF HEPATITIS C | |
AR055669A1 (en) | DERIVATIVES OF 3H - IMIDAZO [4, 5 -B] PIRIDINE AS SELECTIVE INHIBITORS OF GSK3, METHODS AND INTERNEDIARIES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF NEURODE DISEASE. | |
CR9022A (en) | NEW SULFONAMIDE DERIVATIVES AS GLUCOCORTICOID RECEPTOR MODULATORS FOR THE TREATMENT OF INFLAMMATORY DISEASES | |
EA200870127A1 (en) | POLYCYCLIC DERIVATIVES OF AMINO ACIDS AND METHODS OF THEIR APPLICATION | |
CL2008003096A1 (en) | Compounds derived from piperidino-dihydrothienopyrimidines; pde4 inhibitors; pharmaceutical composition comprising them; and use in the treatment of disorders or diseases of the respiratory or gastrointestinal routes, as well as inflammatory diseases of the joints or eyes, among others. | |
UY32978A (en) | CHROMENONE DERIVATIVES | |
CY1108794T1 (en) | CYCLOEXANE SPIRACYCLICAL DERIVATIVES | |
EA200802223A1 (en) | 1,5-DIPHENYLPYRAZOLES II AS HSP90 INHIBITORS | |
AR061643A1 (en) | DERIVED FROM UREAS OF PIPERIDINE OR PIRROLIDINE, METHODS FOR THEIR PREPARATION, A PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM AND THE USE OF THESE IN THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF DISEASES MEDIATED BY ENZYME 11BETA-HSD1. | |
AR071120A1 (en) | DERIVATIVES OF DIOSMETINE, ITS PREPARATION PROCEDURE, THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE IN THE TREATMENT OF CHRONIC VENOUS DISEASES. | |
UY29343A1 (en) | PIRAZOLOPIRIDINAS AND SALTS OF THE SAME, A PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS, A METHOD FOR PREPARING THEM AND THEIR USE. | |
UY28787A1 (en) | DERIVATIVES OF BETA-AMINO ACIDS AS INHIBITORS OF FACTOR XA |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |